Meet each patient’s unique needs

Prescribing ARESTIN for
your patients? Here’s how:

Between ARESTIN on Demand and ARESTIN by Appointment,
we’ve got options for you and your patients.

ISOLATED
periodontal infection?

Use ARESTIN on Demand to have the antibiotic readily available to treat patients with isolated periodontal infection (procedure code: 4342; which covers up to three sites of infection per quadrant) and/or during periodontal maintenance (procedure code: 4910).

Patient is in the chair, and you are planning to treat comprehensively the same day or as part of periodontal maintenance.

Evaluate your average monthly 4342 procedures and order an adequate supply of ARESTIN (each box contains 24 tips). When using ARESTIN on Demand, supply will be delivered within 24 hours.

NOTE: Ask patient for dental insurance information to check for coverage.

Order Online arrow Order by Phone: (1-855-684-7481) arrow Order with Henry Schein arrow

MULTIPLE
periodontal infections?

Use ARESTIN by Appointment to leverage a patient’s prescription benefits to treat one or more quadrants during an SRP appointment as adjunct to scaling and root planning (SRP) (procedure code: 4341; which covers four or more sites of infection per quadrant).

Patient is returning for their initial SRP appointment (within 30 days of diagnosis) to treat comprehensively for a more extensive scheduled SRP.

Create account/log in to the site to complete a simple form that will allow OraPharma's HUB Services team to fill the prescription and evaluate patient's medical and/or dental insurance coverage. HUB Services can also assist you with navigating any prior authorization requirements.

Place order through ARESTIN by Appointment arrow

With ARESTIN, eligible commercially insured patients may be able to receive ARESTIN through their medical prescription benefits. Commercially insured patients may be eligible for a copay as low as $0 through the ARESTIN Copay Assistance Program.†

Meet each patient’s unique needs

pinwheel

Prescribing ARESTIN for
your patients? Here’s how:

Between ARESTIN on Demand and ARESTIN by Appointment, we’ve got
options for you and your patients.

isolated-periodontal-infection
arestin-on-demand-info

Use ARESTIN on Demand to have the antibiotic readily available to treat patients with isolated periodontal infection (procedure code: 4342; which covers up to three sites of infection per quadrant) and/or during periodontal maintenance (procedure code: 4910).

Patient is in the chair, and you are planning to treat comprehensively the same day or as part of periodontal maintenance.

Evaluate your average monthly 4342 procedures and order an adequate supply of ARESTIN (each box contains 24 tips). When using ARESTIN on Demand, supply will be delivered within 24 hours.

NOTE: Ask patient for dental insurance information to check for coverage.

Order Online arrow Order by Phone:
(1-855-684-7481) arrow Order with Henry Schein arrow

isolated-periodontal-infection
arestin-on-demand-info

Use ARESTIN by Appointment to leverage a patient’s prescription benefits to treat one or more quadrants during an SRP appointment as adjunct to scaling and root planning (SRP) (procedure code: 4341; which covers four or more sites of infection per quadrant).

Patient is returning for their initial SRP appointment (within 30 days of diagnosis) to treat comprehensively for a more extensive scheduled SRP.

Create account/log in to the site to complete a simple form that will allow OraPharma's HUB Services team to fill the prescription and evaluate patient's medical and/or dental insurance coverage. HUB Services can also assist you with navigating any prior authorization requirements.

Place order through ARESTIN by Appointment arrow

With ARESTIN, eligible commercially insured patients may be able to receive ARESTIN through their medical prescription benefits. Commercially insured patients may be eligible for a copay as low as $0 through the ARESTIN Copay Assistance Program.†

Contact the ARESTIN Service Center at

1-855-684-7481

to find out which program may help your patient.
Create an account
on the ARESTIN by
Appointment Portal arrow
See More

IMPORTANT SAFETY INFORMATION AND INDICATION

  • ARESTIN® (minocycline HCl) is contraindicated in any patient who has a known sensitivity to minocycline or tetracyclines. Hypersensitivity reactions and hypersensitivity syndrome that included, but were not limited to anaphylaxis, anaphylactoid reaction, angioneurotic edema, urticaria, rash, eosinophilia, and one or more of the following: hepatitis, pneumonitis, nephritis, myocarditis, and pericarditis may be present. Swelling of the face, pruritus, fever and lymphadenopathy have been reported with the use of ARESTIN. Some of these reactions were serious. Post-marketing cases of anaphylaxis and serious skin reactions such as Stevens Johnson syndrome and erythema multiforme have been reported with oral minocycline, as well as acute photosensitivity reactions.
See Less

IMPORTANT SAFETY INFORMATION AND INDICATION

  • ARESTIN® (minocycline HCl) is contraindicated in any patient who has a known sensitivity to minocycline or tetracyclines. Hypersensitivity reactions and hypersensitivity syndrome that included, but were not limited to anaphylaxis, anaphylactoid reaction, angioneurotic edema, urticaria, rash, eosinophilia, and one or more of the following: hepatitis, pneumonitis, nephritis, myocarditis, and pericarditis may be present. Swelling of the face, pruritus, fever and lymphadenopathy have been reported with the use of ARESTIN. Some of these reactions were serious. Post-marketing cases of anaphylaxis and serious skin reactions such as Stevens Johnson syndrome and erythema multiforme have been reported with oral minocycline, as well as acute photosensitivity reactions.
  • THE USE OF DRUGS OF THE TETRACYCLINE CLASS DURING TOOTH DEVELOPMENT MAY CAUSE PERMANENT DISCOLORATION OF THE TEETH, AND THEREFORE SHOULD NOT BE USED IN CHILDREN OR IN PREGNANT OR NURSING WOMEN.
  • Tetracyclines, including oral minocycline, have been associated with development of autoimmune syndromes including a lupus-like syndrome manifested by arthralgia, myalgia, rash, and swelling. Sporadic cases of serum sickness-like reaction have presented shortly after oral minocycline use, manifested by fever, rash, arthralgia, lymphadenopathy and malaise. In symptomatic patients, diagnostic tests should be performed and ARESTIN treatment discontinued.
  • The use of ARESTIN in an acutely abscessed periodontal pocket or for use in the regeneration of alveolar bone has not been studied.
  • The safety and effectiveness of ARESTIN has not been established in immunocompromised patients or in those with coexistent oral candidiasis. Use with caution if there is a predisposition to oral candidiasis.
  • In clinical trials, the most frequently reported nondental treatment-emergent adverse events were headache, infection, flu syndrome, and pain.

To report SUSPECTED ADVERSE REACTIONS, contact Bausch Health US, LLC at 1-800-321-4576 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

INDICATION

ARESTIN® (minocycline HCl) Microspheres, 1mg is indicated as an adjunct to scaling and root planing (SRP) procedures for reduction of pocket depth in patients with adult periodontitis. ARESTIN® may be used as part of a periodontal maintenance program, which includes good oral hygiene and SRP.

Click here for full Prescribing Information.